Fritz Van Rhee

42PUBLICATIONS
189CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyImmunogenetics (incl. genetic immunology)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Jul 28, 2026
Efficacy and Safety of CAR-T Cell Therapy and Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma with Renal Impairment: A Propensity Score-Matched Analysis.

|Mar 31, 2026
Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients.

Hira Cheema, Asis Shrestha, Syed Naqvi

|Mar 03, 2026
Elucidating the grading intricacies of idiopathic multicentric Castleman disease histopathology: a pathologist's perspective.

Daisy V Alapat, Payam Etebari, Frits Van Rhee

|Jan 06, 2026
Peripheral blood immune cell profiling and response to BCMA CAR-T cell therapy in relapsed refractory multiple myeloma.

Toshali Pandey, Bhavesh Mohan Lal, Jawad Alrawabdeh

|Nov 07, 2025
Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study.

Samer Al Hadidi, Aniko Szabo, Bhavesh Mohan Lal

|Oct 16, 2025
Equal survival for Black Americans with multiple myeloma when appropriately matched to White Americans.

David E Mery, Guido Tricot, Samer Al Hadidi

Pageof 7

Frequent Collaborators

23 joint publications

Caroline Schinke

17 joint publications

Samer Al-Hadidi

10 joint publications

David C Fajgenbaum

9 joint publications

Meera Mohan